2022 Tandem Meetings

Eva Karam PharmD, BCOP⁽¹⁾, Asad Bashey MD, PhD⁽²⁾, H. Kent Holland MD⁽²⁾, Lawrence E Morris MD⁽²⁾, Melhem M Solh MD⁽²⁾, Scott R. Solomon MD⁽²⁾, Asim Ahmed, MD⁽³⁾, Matthew Smollin, PharmD⁽³⁾

⁽¹⁾Northside Hospital, Atlanta, GA ⁽²⁾Blood and Marrow Transplant Program at Northside Hospital, Atlanta GA ⁽³⁾Karius, Inc., Redwood City, CA

The Karius Test provided positive results faster than conventional diagnostics in 57% of patients and led to targeted antifungal therapy in 71% of patients with mucormycosis. The Karius Test also showed a decline in microbial cell-free DNA in all patients where serial tests were performed to monitor the infection burden and treatment effectiveness.* 

*This study was a cohort of seven patients